Malaria Information and Prophylaxis, by Country [B]

The information presented in this table is consistent 1 with the information in the CDC Health Information for International Travel (the “Yellow Book”).

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Malaria Information and Prophylaxis by Country
Country Areas with Malaria Drug Resistance2 Malaria Species3 Recommended Chemoprophylaxis4 Key Information Needed and Helpful Links to Assess Need for Prophylaxis for Select Countries
Bahamas, The None Not Applicable Not Applicable Not Applicable
Bahrain None Not Applicable Not Applicable Not Applicable
Bangladesh All areas, except in the city of Dhaka. Chloroquine P.falciparum 90%,
P. vivax 10%,
and P. malariae rare
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6
Barbados None Not Applicable Not Applicable Not Applicable
Belarus None Not Applicable Not Applicable Not Applicable
Belgium None Not Applicable Not Applicable Not Applicable
Belize Rare locally transmitted cases. None in Belize City and islands frequented by tourists such as Ambergris Caye. None P.vivax 100% Mosquito avoidance only.
Benin All Chloroquine P. falciparum >85%, P. ovale 5-10%,
P. vivax rare
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6
Bermuda (U.K.) None Not Applicable Not Applicable Not Applicable
Bhutan Rare cases in rural areas <1,700 m (5,577 ft) in districts along the southern border shared with India. Also rare seasonal cases May-September in Ha, Lhuentse, Monggar, Punakha, Trashigang, Trongsa, Tsirang, Yangtse, and Wangdue.  None in districts of Bumthang, Gaza, Paro, and Thimphu. Chloroquine P. falciparum 70%,

P. vivax 30%

Mosquito avoidance only.

 

Bolivia All areas below 2,500 m (8,202 ft). None in the city of La Paz Chloroquine P. vivax 93%,

P. falciparum 7%

Atovaquone-proguanil, doxycycline, mefloquine, primaquine,6 or tafenoquine6
Bosnia and Herzegovina None Not Applicable Not Applicable Not Applicable
Botswana Present in the following subdistricts: Botete, Chobe (including Chobe National Park), Ngami, Okavango, and Tuteme. Also present in the following districts: Bobirwa, Northeast (including Francistown), Ghanzi, Mahalapaye, and Serowe Palapye. Rare cases in the districts of Kgalagadi North, Keneng West, and Southern. None in the city of Gaborone. Chloroquine P. falciparum 90%,
P. vivax 5%,
P. ovale 5%
Subdistricts of Botete, Chobe (including Chobe National Park), Ngami, Okavango, and Tuteme and districts or Bobirwa, Northeast (including Francistown), Ghanzi, Mahalapaye, and Serowe Palapye: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6. Areas with rare cases: mosquito avoidance only. 1) City(ies) of travel
2) District(s) of travel
Map of districts in BotswanaExternal
Brazil All areas of the states of Acre, Amapá, Amazonas, Rondonia, and Roraima. Also present in the states of Maranhão, Mato Grosso, and Para, but rare cases in their capital cities. Rare cases in the rural areas of the states of Espirito Santo, Goias, Mato Grasso do Sul, Piaui, and Tocantins. Rare cases in the rural forested areas of the states of Rio de Janeiro and São Paolo. No malaria in the cities of Brasilia, Rio de Janeiro, São Paolo, and none at Iguaçu Falls Chloroquine P. vivax 85%,
P. falciparum 15%
States of Acre, Amapá, Amazonas, Rondonia, and Roraima. States of Maranhão, Mato Grosso, and Para (but not their capital cities): Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6. Areas with rare cases: Mosquito avoidance only.
British Indian Ocean Territory; Includes Diego Garcia (U.K.) None Not Applicable Not Applicable Not Applicable
Brunei None Not Applicable Not Applicable Not Applicable
Bulgaria None Not Applicable Not Applicable Not Applicable
Burkina Faso All Chloroquine P. falciparum >80%,
P. ovale 5-10%,
P. vivax rare
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6
Burma (Myanmar) Present at altitudes < 1,000 m (3,281 ft), including Bagan. Rare transmission above 1,000m (3,281 ft). Chloroquine
Mefloquine
P. falciparum 60%,
P. vivax 35%, P. malariae, P. ovale, and P. knowlesi rare
In the provinces of Bago, Kachin, Kayah, Kayin, Shan, and Tanintharyi <1,000 m (3,281 ft): Atovaquone-proguanil, doxycycline, or tafenoquine.
All other areas <1000 m (3,281 ft): Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6. Above 1,000m (3,281 ft):
Mosquito avoidance only.
Burundi All Chloroquine P. falciparum 86%,
P. malariae, P.ovale, and P. vivax 14% combined.
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6

1. Factors that affect local malaria transmission patterns can change rapidly and from year to year, such as local weather conditions, mosquito vector density, and prevalence of infection. Information in these tables is updated regularly.
2. Refers to P. falciparum malaria unless otherwise noted.
3. Estimates of malaria species are based on best available data from multiple sources.
4. Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. All travelers should seek medical attention in the event of fever during or after return from travel to areas with malaria.
5. This risk estimate is based largely on cases occurring in US military personnel who travel for extended periods of time with unique itineraries that likely do not reflect the risk for the average US traveler.
6. Primaquine and tafenoquine can cause hemolytic anemia in persons with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients must be screened for G6PD deficiency prior to starting primaquine.

Page last reviewed: March 27, 2019